Cargando…
Corrigendum: Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease
Autores principales: | Di Villeneuve, Larissa, Souza, Ive Lima, Tolentino, Fernanda Davila Sampaio, Ferrarotto, Renata, Schvartsman, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063728/ https://www.ncbi.nlm.nih.gov/pubmed/33898325 http://dx.doi.org/10.3389/fonc.2021.669486 |
Ejemplares similares
-
Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease
por: Di Villeneuve, Larissa, et al.
Publicado: (2020) -
Current management and future challenges in salivary glands cancer
por: Locati, Laura D., et al.
Publicado: (2023) -
Corrigendum: Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma
por: Fang, Qigen, et al.
Publicado: (2021) -
Salivary glands adenoid cystic carcinoma: a molecular profile update and potential implications
por: da Silva, Fernanda Jardim, et al.
Publicado: (2023) -
Salivary gland cancers in elderly patients: challenges and therapeutic strategies
por: Colombo, Elena, et al.
Publicado: (2022)